Drug Trial Radar · NCT04449484
Multiple Ascending Dose Study of MEDI1341 in Patients With Parkinson's Disease
Last checked: Nov 19, 2026Latest source record: Jun 3, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
25
Actual
Start
Aug 4, 2020
Primary completion
Jan 5, 2022
Study completion Jan 5, 2022
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- Collaborators
- Takeda
- First posted
- Jun 26, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, double-blind, placebo-controlled study of multiple ascending iv doses of MEDI341 in male and female subjects with Parkinson's Disease.
Conditions
- Parkinson's Disease
Interventions
MEDI1341Drug
Intravenous infusion over 60 minutes
PlaceboOther
Intravenous infusion over 60 minutes
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse EventsTime frame: 28 weeks
- Vital SignsTime frame: 21 weeks
- Oral Body TemperatureTime frame: 21 weeks
- Body WeightTime frame: 21 weeks
- Safety Laboratory TestsTime frame: 21 weeks
- ElectrocardiogramsTime frame: 21 weeks
- Ophthalmic assessmentsTime frame: 21 weeks
- Suicidal IdeationTime frame: 21 weeks
- Cognitive impairmentTime frame: 21 weeks
- ElectrocardiogramsTime frame: 21 weeks
- ElectrocardiogramsTime frame: 21 weeks
- ElectrocardiogramsTime frame: 21 weeks
- ElectrocardiogramsTime frame: 21 weeks
- ElectrocardiogramsTime frame: 21 weeks
- ElectrocardiogramsTime frame: 21 weeks
- ElectrocardiogramsTime frame: 21 weeks
- Suicidal BehaviourTime frame: 21 weeks
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Long Beach, California
Research Site
Hallandale, Florida
Research Site
Atlanta, Georgia
Research Site
Farmington Hills, Michigan
Research Site
Spokane, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.